Association of TT Virus Primary Infection with Rhinitis in a Newborn
Author(s) -
Philippe Biagini,
Rémi N. Charrel,
Philippe de Micco,
Xavier de Lamballerie
Publication year - 2003
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/345552
Subject(s) - medicine , primary (astronomy) , virus , association (psychology) , virology , pediatrics , philosophy , physics , epistemology , astronomy
of tuberculosis disappeared with no evidence of recurrence at 1-year follow-up. Drug interactions between Rif and protease inhibitors have prompted clinical studies of HIV-infected patients that have documented the efficacy of Rib as a substitute for Rif in the 6-month antituberculous regimen [2–4]. Intolerance to Rif is not rare and could be another indication for Rib. The tolerance profile of Rib is distinct from that of Rif, and there is no indication that cross-toxicity is of concern [5]. In conclusion, a regimen that contains Rib could be the first-choice alternative for the treatment of patients with tuberculosis who are intolerant to Rif.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom